Antiribonucleoprotein antibodies in children with human immunodeficiency virus infection: comparative study with childhoodonset systemic lupus erythematosus

Pediatric AIDS and HIV Infection

Volumn 7, Issue 6, 1996, Pages 401-408

  González, Carlos M ^a   Löpez Longo, Francisco J ^a   Monteagudo, Indalecio ^a   Grau, Raquel ^a   Rodrfguez Mahou, Margarita ^a   St Cyr, Claire ^a   Lapointe, Normand ^a   Carreno, Luis ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; COUNTER IMMUNOELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COUNTERIMMUNOELECTROPHORESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOBLOTTING; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RIBONUCLEOPROTEINS, SMALL NUCLEAR;

EID: 0030334398     PISSN: 10455418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Berman A, Espinoza LR, Diaz JD, et al., Rheumatic manifestations of HIV infection. Am J Med 1988:85:59-64.
2. Calabrese LH, The rheumatic manifestations of infection with the HIV. Semin Arthritis Rheum 1989:18:225-39.
3. Buskila D, Gladman D, Musculoskeletal manifestations of infection with HIV. Rev Infect Dis 1990; 12:223-35.
4. Morrow WJW, Isenberg DA, Sobol RE, et al, AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol 1991 ;58: 163-80.
5. Ziegler JL, Stiles DP, Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol 1986:41:30513.
6. Schattner A, Rager-Zisman B, Virus-induced autoimmunity. Rev Infect Dis 1990:12:204-22.
7. Sonnabend J, Witkin SS, Purtilo DT, Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homosexuals. JAMA 1983:249:2370-4.
8. Kyriakis K, Tosca A, Katsantonis J, Detection of autoimmunity parameters in the acquired immunodeficiency syndrome. Int J Dermatol 1992;31:113-6.
9. Medina-Rodriguez F, Guzman C, Jara LJ, et al, Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J Rheumatol. 1993;20:1880-4.
10. Mayer-Siuta R, Keil LB, DeBari VA, Autoantibodies and circulating immunocomplexes in subjects infected with human immunodeficiency virus. Med Microbiol Immunol (Berlin) 1988;177:189-94.
11. Centric A, Blaschek M, Julien C, et al., Non-organ specific autoantibodies in individuals infected with type 1 human immunodeficiency virus. Clin Immunol Immunopathol 1991;59:487-94.
12. Carreno L, Monteagudo I, Lopez-Longo FJ, et al., Anticardiolipin antibodies in pédiatrie patients with human immunodeficiency virus. J Rheumatol 1994;21:1344-6.
13. Rivera J, Monteagudo I, Löpez-Longo FJ, et al., Anticardiolipin antibodies in drug addicted patients with AIDS. Ann Rheum Dis 1991;50:338.
14. Stimmler MM, Quismorio FP, McGehee W, et al., Anticardiolipin antibodies in AIDS. Arch Intern Med 1989;149:1833-5.
15. Argov S, Schattner A, Burstein R, et al., Autoantibodies in male homosexual and human immunodeficiency virus infection. Immunol Lett 1991;30:31-6.
16. Muller S, Richalet P, Laurent-Crawford A, et al., Autoantibodies typical of non-organ-specific autoimmune diseases in HIVseropositive patients. AIDS 1992;6:933-42.
17. Rodriguez-Mahou M, Lopez-Longo FJ, Lapointe N, et al., Autoimmune phenomena in children with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Acta Pediatr 1994; Suppl 400:31-41.
18. Lafeuillade A, Ritter J, Pellegrino P, et al., Lack of antinuclear antibodies during HIV infection. AIDS 1993 ;7:893-902.
19. Berman A, Reboredo G, Spindler A, Rheumatic manifestations in populations at risk for HIV infection: the added effect of HIV. J Rheumatol 1991 ;18:1564-7.
20. Cassani F, Baffoni L, Raise E, et al., Serum non-organ specific autoantibodies in human immunodeficiency virus 1 infection. J ClinPathol 1991;44:64-8.
21. Monteagudo I, Gonzalez CM, Löpez-Longo FJ, et al., Autoantibodies in human immunodeficiency virus infected patients. Br J Rheumatol 1994;33(Suppl 1):27.
22. Löpez-Longo FJ, Rodriguez-Mahou M, Monteagudo I, et al., Manifestaciones reumâticas en ninos infectados por el VIH. Rev EspReumatol 1994;21:222-6.
23. Tan EM, Cohen AS, Fries JF, et al., The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
24. Moreno AC, Löpez-Longo FJ, Gonzalez CM, et al., Comparative serological analysis of adult and childhood onset systemic lupus erythematosus. Arthritis Rheum 1994;37(9):S318.
25. Kurata N, Tan EM, Identification of antibodies to nuclear acidic antigen by counterimmunoelectrophoresis. Arthritis Rheum. 1976;19:574-8.
26. Lopez-Longo FJ, Fernândez J, Monteagudo I, et al., Evoluciôn clinica y serolögica en pacientes con enfermedad mixta del tejido conectivo. Rev Clfn Exp 1.994; 194:682-8.
27. Clark GM, Reichlin M, Tomasi TB, Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1.969; 102:117-22.
28. Boire G, Löpez-Longo FJ, Lapointe S, Ménard HA, Sera from patients with autoimmune disease recognize conformational determinants on the 60 kd Ro/SS-A protein. Arthritis Rheum 1.991;34:722-30.
29. Lopez-Longo FJ, Rodriguez-Mahou M, Escalona M, et al., Heterogeneity of the anti-Ro(SS-A) response in rheumatic diseases. J Rheumatol 1994;21:1450-6.
30. Towbin H, Staehelin T, Gordon J, Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sei USA 1979;76:4350-5.
31. Tan EM, Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989:44:93-151.
32. Gioud M, Chamot AM, Bourgeois P, et al., Différences symptomatiques et pronostiques selon la communanté ethnique dans le lupus erythemateus systemique. Etude contrôlée sur trois populations. Press Med 1988;17:103-6.
33. Bernstein RM, Bunn CC, Hughes CGV, et al., Cellular proteins and RNA antigens in autoimmune diseases. Mol Biol Med 1984;2:105-20.
34. Wallace C, Schaller JG, Emery H, Wedgewood, Prospective study of childhood systemic lupus erythematosus. Arthritis Rheum 1978;21:599-600.
35. Tejani A, Nicastri AD, Chen CK, et al., Lupus nephritis in Black and Hispanic children. Am J Dis Child 1983;137:481-3.
36. Glidden RS, Mantzouranis EC, Borel Y, Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in 55 patients. Clin Immunol Immunopathol 1983;29:196210.
37. Caeiro F, Michielson FMC, Bernstein R, et al., Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981;40:325-31.
38. Lacks S, White P, Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 1990; 17:941-5.
39. El-Garf A, Salah S, Juvenile Systemic lupus erythematosus among Egyptian children. J Rheumatol 1990;17:1168-70.
40. Cervera R, Khamashka MA, Font J, et al., Systemic lupus erythematosus: clinical and immunologie patterns of disease expression in a cohort of 1000 patients. The European Working Party on SLE. Medicine 1993;72:113-24.
41. Lehman TJA, McCurdy DK, Bernstein BH, et al., Systemic lupus erythematosus in the first decade of life. Pediatrics 1989;83:235-39.
42. Venables PJW, Epitope mapping of ribonucleoprotein antigens: answer without question? Clin Exp Immunol 1993;94:225-6.
43. Pascual V, Capra JD, Human immunoglobulin heavy-chain variable region genes: organization, polymorphisms and expression. Adv Immunol 1991;49:1-70.
44. Ward MM, Dawson DV, Kredich DW, Pisetsky DS, Expression of IgM and IgG autoantibodies in pédiatrie and adult systemic lupus erythematosus. Clin Immunol Immunopathol 1990;55:27384.
45. Zhang W, Reichlin M, IgM anti-A and D snRNP proteins and IgM anti-dsDNA are closely associated in systemic lupus erythematosus sera. Clin Immunol Immunopathol 1995;74:70-6.
46. Gordon T, Mavrangelos C, McCluskey J, Restricted epitope recognition by precipitin-negative anti-La/SS-B-positive sera. Arthritis Rheuma 1992:35:663-6.
47. Zhang F, Kurien BT, Harley JB, Scofield RH, Development of the humoral autoantibody response to 60kD-Ro in patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:sl73.
48. Carruthers CJ, Bell DA, Production and characterization of human hybridome monoclonal anti-Sm and anti-UlRNP antibod-ies spontaneously produced from normal human lymphocytes. J Autoimmun 1992;5:527-44.
49. Rokeach LA, Jannatipour M, Hoch SO, Heterologous expression and epitope mapping of a human small nuclear ribonucleoproteinassociated Sm B/B' autoantigen. J Immunol 1990; 144:1015-22.
50. Buyon JP, Itescu S, Slade SG, Winchester R, Antibodies to components of SSA/Ro-SSB/La in HIV patients with diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 1990;33:s33.
51. Lee LA, Roberts CM, Frank MB, et al., The autoantibody response to Ro/SS-A in cutaneous lupus erythematosus. Arch Dermatol 1994; 130:1262-8.
52. Hang L, Slack JH, Amundson C, et al., Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med 1983;157:874-83.
53. Klinman DM, Steinberg AD, Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 1987;165:1755-60.
54. Theofilopoulos AN, Dixon FJ, Etiopathogenesis of murine systemic lupus erythematosus. Immunol Rev 1981;55:179-92.
55. Hayakawa K, Hardy RR, Honda M, et al., Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sei USA 1984;81:2494-8.
56. Hardin JA, The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1986;29:457-60.
57. Shlomchik MJ, Marshak-Rothstein A, Wolfwicz CB, et al., The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805-7.
58. Fisher CL, Eisenberg RA, Cohen PL, Quantitation and IgG subclass distribution of anti-chromatin autoantibodies in SLE mice. Clin Immunol Immunopathol 1988;46:205-8.
59. Gharavi AR, Chu JL, Elkon KB, Autoantibodies in human systemic lupus erythematosus are not due to random polyclonal B cell activation. Arthritis Rheum 1988;31:1337-40.
60. Oldstone M, Molecular mimicry and autoimmune disease. Cell 1987;50:819-20.
61. Walker EJ, Jeffrey PD, Polymyositis and molecular mimicry: a mechanism of autoimmunity. Lancet 1986;2:605-7.
62. Luo AM, Garza KM, Hunt D, Tung KSK, Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest 1993;92:2117-23.
63. Kreig AM, Steinberg AD, Retroviruses and autoimmunity. J Autoimmunol 1990;3:137-66.
64. Schwartz BD, Infectious agents, immunity and rheumatic diseases. Arthritis Rheum 1990;33:457-65.
65. De Keyser F, Hoch SO, Takei M, et al., Cross-reactivity of the B/B' subunit of the Sm ribonucleoprotein autoantigen with proline-rich polypeptides. Clin Immunol Immunopathol 1992;62:285-90.
66. Query C, Keene J, A human autoimmune protein associated with Ul RNA contains a region of homology that is cross-reactive with retroviral p30a antigen. Cell 1987;51:211-20.
67. Maul GG, Jiménez SA, Riggs E, Ziemnicka-Kotina D, Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA-topoisomerase I. Proc Natl Acad Sei USA 1989:86:8492-6.
68. Carry RF, Extensive antigenic mimicry by retrovirus capsid proteins. AIDS Res Hum Retroviruses 1990:6:1361-2.
69. Kohsaka H, Yamamoto K, Fujii H, et al., Fine epitope mapping of the human SS-B/La protein. Identification of a distinct autoepitope homologous to a viral Gag protein. J Clin Invest 1990:85:1566-74.
70. Douvas A, Takehana Y, Cross-reactivity between autoimmune anti-Ul snRNP antibodies and neutralizing epitopes of HIV-1 gp 120/41. AIDS Res Hum Retroviruses 1994; 10:253-61.
71. Rucheton M, Gaafland H, Fanton H, et al., Presence of circulating antibodies against gag-gene MuLV proteins in patients with autoimmune connective tissue diseases. Virology 1985; 144:46880.
72. Talal N, Carry RF, Schur PH, et al., A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990;85:1866-71.
73. Ranki A, Kurki P, Riepponen S, Stephansson E, Antibodies to retroviral proteins in autoimmune connective tissue disease. Relation to clinical manifestations and ribonucleoprotein autoantibodies. Arthritis Rheum 1992;35:1483-91.
74. Blomberg J, Nived O, Pipkorn R, et al., Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Arthritis Rheum 1994;37: 57-66.
75. Dang H, Dauphinée M, Talal N, et al., Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum 1991:34:1336-7.
76. Haustein UF, Pustowoit B, Krusche U, Hermann K, Antibodies to retrovirus proteins in scleroderma. Acta Derm Venereol 1993;73:116-8.
77. Talal N, Dauphinee MJ, Dany M, et al., Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arthritis Rheum 1990:33:774-81.
78. Leön-Monzön M, Lamperth L, Dalakas MC, Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis. Muscle Nerve 1993; 16:408-13.
79. Horsfall AC, Molecular mimicry and autoantigens in connective tissue diseases. Mol Biol Rep 1992; 16:139-47.
80. Neurath AR, Strick N, Li YY, Jiang G, Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins. AIDS Res Hum Retroviruses 1993;9: 1195-208.
81. Kalden JR, Winkler T, Krapf F, Are retroviruses involved in the aetiology of rheumatic diseases? Br J Rheumatol 1991 ;30 (suppl l):63-9.
82. Venables P, Brookes S, Retroviruses: Potential aetiological agents in autoimmune rheumatic disease. Br J Rheumatol 1992;31: 841-6.